Biotechnology Stocks I Performance Guide: Protagonist Therapeutics, Inc. (PTGX)
PTGX has no dividends.
Table and Chart of PTGX Performance
See what a $1,000 investment in PTGX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| PTGX Returns | |
|---|---|
| Start Date | Sep-30-2016 |
| Start Price | $21.13 |
| End Date | May-07-2024 |
| End Price | $25.79 |
| # Prices | 93 |
| Min Date | Nov-30-2018 |
| Min Price | $6.47 |
| Max Date | Jul-30-2021 |
| Max Price | $49.43 |
| Total Return | 22.05% |
| Annualized Return | 2.60% |
| Current Value of $1,000 Purchase | $1,221 |
| Number Returns | 4,278 |
| Average Return | 55.53% |
| Number Profitable Returns | 2,624 |
| Percent Profitable Returns | 61.34% |
| Number Unprofitable Returns | 1,654 |
| Percent Unprofitable Returns | 38.66% |
| Profitable to Unprofitable Returns Ratio | 1.59 |
| PTGX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $1,545,832,000 |
| Beta | 2.053 | Price to Sales | 26.26 |
| Earnings per Share | $-1.3900 |
| PE Ratio | None |
| PE to Growth Ratio | 0 |
| Price to Book | 4.68 |
| PRICE DATA | |
| 52 Week High | $33.34 |
| 52 Week Low | $13.72 |
| Analyst Target Price | $44.2 |
| 50-Day Moving Average | $28.05 |
| 200-Day Moving Average | $21.96 |
| FINANCIAL DATA | |
| Revenue per Share | $1.057 |
| Revenue | $60,000,000 |
| Profit Margin | -131.6% |
| Return on Equity | -28.6% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
PTGX Compare Returns with S&P 500
PTGX Trendline Chart
PTGX Moving Average Chart
PTGX Stock Return Map - See Patterns of Gains and Losses
PTGX Stock Returns/Purchase Dates